Phase 1 Ovarian Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been diagnosed with advanced ovarian cancer, or another type of cancer that has a specific protein called "claudin6" present on the cancer cells
- You are expected to live for more than 12 weeks
- Your heart, lungs, liver, and kidneys are working well enough as shown by medical tests
- A sample of your own natural killer (NK) immune cells can be collected and successfully modified in the lab to meet certain activity levels against cancer cells (the trial team will assess this)
- You are willing and able to read, understand, and sign a consent form agreeing to take part
Who may not be able to join:
- You have previously received any form of gene therapy
- Your tumor is larger than 25 cm in size
- You have a serious viral infection such as hepatitis B, hepatitis C, or HIV
- You have tested positive for HIV
- You have previously had a liver or kidney transplant
- You currently have an active infection caused by bacteria, a virus, fungi, or similar
- You are pregnant or currently breastfeeding
- You are taking regular steroid medication at a certain daily dose or higher (confirm with trial site for exact details)
- You have another serious health condition that the trial doctors feel makes participation unsuitable
- There are any other reasons the trial doctors feel make participation unsuitable (confirm with trial site)
⚠️ Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Zhenfeng Zhang, MD, PHD, Second Affiliated Hospital of Guangzhou Medical University
Phone: +862039195966
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Safety by Common Terminology Criteria for Adverse Events (CTCAE) V5.0
Can't join this trial?
Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.